Opioid Analgesics (finished) Flashcards

Describe the ways in which drugs can relieve pain Compare and contrast the terms opioid, opiate and narcotic Discuss the advantages and disadvantages (limitations) of opioids and NSAIDs in terms of type and level of pain, adverse effects and drug dependence Describe and distinguish among the subtypes of opioid receptors Define the terms agonist, antagonist, mixed agonist-antagonist and partial agonist in terms of opioids and give examples of each type of drug List the advantages a

1
Q

Describe the ways in which drugs can relieve pain

A

Eliminate cause of pain:
Anti-inflammatory (NSAIDs)
Chemotherapy (including antimicrobials)
Antiulcer

Prevent transmission:
Local anesthetics

Affect the way pain is perceived:
General anesthetics
Opioids

Affect patient’s reaction to pain:
Anxiolytics
Opioids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Compare and contrast the terms opioid, opiate and narcotic

A

Opiate: drug derived from opium poppy
Opium, morphine, codeine

Opioid: more generic term; all substances, endogenous and exogenous, that bind opioid receptors
Endorphins (endogenous)
Morphine, also an opiate
Fentanyl, synthetic so not an opiate

Narcotic: originally meant sleep inducing (Greek “narcos”
Now a legal term encompassing illicit drug use
Includes opioids, cannabinoids, stimulants, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Discuss the advantages and disadvantages (limitations) of opioids and NSAIDs in terms of type and level of pain, adverse effects and drug dependence

A

be able to do this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe and distinguish among the subtypes of opioid receptors

A
Mu (μ)
Analgesia
Respiratory depression
Decreased gastrointestinal motility
Physical Dependence

Kappa (κ)
Analgesia
Sedation
Decreased gastrointestinal motility

Delta (δ)
Modulates μ activity

ORL1 – Orphanin opioid receptor-like 1
Structurally similar to μ but insensitive to opioid ligands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give examples of opioids with active and toxic metabolites and the significance of this information in the treatment of pain

A

Pharmacologically Active
Morphine-6-glucoronide (morphine metabolite)
Excreted in urine, so can impact morphine’s effect and duration if renal function is compromised

Toxic metabolites
Normeperidine, a metabolite of meperidine
Excitotoxic: tremor, twitching, convulsions
Meperidine should only be used acutely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the clinical uses of opioids and how they relate to their sites of action centrally

A

Cortex:
Pain perception, reaction to pain, euphoria, sedation

Medulla:
Respiratory depression
Antitussive effects
Nausea, vomiting
Thermoregulation

Spinal Cord:
Depresses pain reflexes
Stimulates non-pain reflexes

Eye, occulomotor nerve:
Miosis (pinpoint pupils) – little tolerance so good indicator of opioid use

Vagus nerve:
Bradycardia
Increased GI tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mu (μ)

A

Analgesia
Respiratory depression
Decreased gastrointestinal motility
Physical Dependence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Kappa (κ)

A

Analgesia
Sedation
Decreased gastrointestinal motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Delta (δ)

A

Modulates μ activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ORL1 – Orphanin opioid receptor-like 1

A

Structurally similar to μ but insensitive to opioid ligands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Opioid Receptor Signal Transduction

A

Presynaptic inhibition of afferent neurons:
Receptor activation blocks voltage-gated Ca2+ channels
Reduced release of glutamate and substance P

Postsynaptic inhibition:
Receptor activation opens K+ channels
Inhibit excitation of postsynaptic neuron

Enhanced inhibition of ascending pathway:
Pain inhibitory neuron indirectly activated

Opioid receptor activation blocks release of GABA from inhibitory interneuron

Greater inhibition of nociceptive processing in dorsal horn of spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Agonist

A

Receptor binding produces effect

Examples:
Morphine
Methadone
Oxycodone
Heroin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antagonist

A

Receptor binding produces no effect
Reverses effect of morphine-like opioids

Examples:
Naloxone
Naltrexone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Partial Agonist

A

Less efficacy than full agonist
Lower abuse potential

Example:
Buprenorphine
Often used with naloxone, an antagonist (Suboxone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mixed Agonist-Antagonist

A

Agonist at one receptor
Antagonist at another

Example:
Pentazocine
Agonist at Kappa
Antagonist at Mu

Clinical relevance:
can initiate withdrawal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Routes of Administration:

Oral

A

Convenient, but high first pass metabolism can be limiting
Slower onset, delayed peak effect, longer duration (relative to parenteral routes)
Better for chronic treatment

First pass metabolism: drugs absorbed from GI tract go to liver, are rapidly and efficiently metabolized
Oral morphine clinically effective, just requires 3-6x higher dose (relative to parenteral)
By contrast, methadone less impacted by first pass metabolism (1.5-2x higher dose)
Altered liver function – Clinical relevance?

17
Q

Routes of Administration:

Intravenous

A

Precise and accurate dosing
Rapid onset, but increased risk of adverse effects
Bolus versus continuous
Can be patient controlled (PCA)

18
Q

Routes of Administration:

Intramuscular/Subcutaneous

A

Rapid onset

Duration between oral and IV

19
Q

Routes of Administration:

Spinal

A

Longer duration at lower doses than systemic
Can avoid some brain-mediated adverse effects
Respiratory depression

20
Q

Routes of Administration:

Rectal suppository

A

Administration may be easily discontinued

21
Q

Routes of Administration:

Buccal/Sublingual

A

Faster onset than oral, avoids first pass metabolism
Convenient (no injection)
Example: Fentanyl “lollipop”

22
Q

Routes of Administration:

Transdermal

A

Convenient, avoids first pass metabolism
Better for chronic treatment
Examples: Fentanyl, Buprenorphine

23
Q

Sites of action and effects outside CNS

A

GI Tract:
Constipation, decreased gastric emptying, cramping, spasm
Slow tolerance, so always an issue with opioid therapy

Bronchiolar constriction (high doses)

Uterus – prolongs labor

Ureters – difficulty urinating

Causes histamine release
Flushing and itching of the skin

24
Q

Therapeutic uses

A

Analgesia
Especially severe pain
Cancer, chronic illness

Obstetric labor
Crosses placental barrier (neonatal respiratory depression)
Slows progress of labor

Anesthesia
Pre- and post-surgery
Sedative, anxiolytic, analgesic
Cardiovascular surgery
Minimizes CV depression

Cough
Codeine, dextromethorphan (non-opioid)

Diarrhea
GI effect (constipation)
All opioids effective
Loperamide (Imodium)
Doesn’t cross BBB
Diphenoxylate + Atropine (Lotomil)
Atropine – anticholinergic to discourage abuse
25
Q

Acute overdose

A

Naloxone
Short duration of action
Single dose – could relapse after 1-2 hrs
Injection to avoid first pass

26
Q

Addiction

A

Naltrexone
Orally effective
Single dose, alternate days blocks heroin effects
Prevent relapse in opioid addiction and alcohol addiction

27
Q

Opioid tolerance

A

Reduction in effect over time with repeated delivery
Increase in dose required for equivalent response

Rate of tolerance varies with endpoint

28
Q

Opioid dependence

A

Removal of drug, or administration of antagonist (e.g., naloxone) leads to withdrawal syndrome

Physical Dependence

Psychological Dependence

Addiction: Compulsive use, drug seeking behavior
Driven by euphoria, indifference to stimuli, sedation, “rush”
Methadone treatment: orally effective, long t1/2, low cost
Buprenorphine + naloxone (Suboxone)
Partial agonist + antagonist, can precipitate withdrawal
Lower abuse potential

29
Q

Opioid withdrawal

A

Unpleasant but not life threatening

Rhinorrhea, lacrimation, yawning, chills, gooseflesh (piloerection), hyperventilation, hyperthermia, mydriasis, muscular aches, vomiting, diarrhea, anxiety, and hostility

Onset, intensity and duration determined by drug used and degree of physical dependence

Reintroduction of opioid eliminates withdrawal symptoms